Skip to main content
. Author manuscript; available in PMC: 2024 Apr 24.
Published in final edited form as: Cardiovasc Drugs Ther. 2022 Jan 13;37(3):519–527. doi: 10.1007/s10557-021-07298-5

Fig. 4.

Fig. 4

Freedom from nonmajor bleeds comparing patients on warfarin to those on DOACs. p represents log-rank p value. Kaplan–Meier curves comparing patients on warfarin to those on DOACs